27.81
price up icon0.94%   0.26
after-market Dopo l'orario di chiusura: 27.80 -0.010 -0.04%
loading

Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie

pulisher
03:49 AM

6,600 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Jane Street Group LLC - Defense World

03:49 AM
pulisher
Jun 04, 2025

40,379 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Purchased by Millennium Management LLC - Defense World

Jun 04, 2025
pulisher
Jun 01, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 01, 2025
pulisher
May 28, 2025

Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 28, 2025
pulisher
May 28, 2025

Bright Minds Showcases Revolutionary CNS Drug Portfolio at Major Jefferies Healthcare Conference - Stock Titan

May 28, 2025
pulisher
May 26, 2025

What is Chardan Capital’s Forecast for DRUG FY2025 Earnings? - Defense World

May 26, 2025
pulisher
May 26, 2025

HC Wainwright Issues Pessimistic Outlook for DRUG Earnings - Defense World

May 26, 2025
pulisher
May 23, 2025

Chardan Capital Reiterates “Buy” Rating for Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

May 23, 2025
pulisher
May 21, 2025

Bright Minds Biosciences (DRUG) Receives Consistent 'Buy' Rating from Chardan Capital | DRUG Stock News - GuruFocus

May 21, 2025
pulisher
May 20, 2025

Bright Minds (DRUG) Schedules Virtual R&D Day to Discuss Epileps - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025 - The Manila Times

May 20, 2025
pulisher
May 20, 2025

Top Neurologists Reveal Latest Absence Epilepsy Breakthrough: Bright Minds Showcases Phase 2 Trial Progress - Stock Titan

May 20, 2025
pulisher
May 18, 2025

FY2025 Earnings Forecast for DRUG Issued By Chardan Capital - Defense World

May 18, 2025
pulisher
May 18, 2025

How To Trade (DRUG) - news.stocktradersdaily.com

May 18, 2025
pulisher
May 16, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Upgraded at Cantor Fitzgerald - Defense World

May 16, 2025
pulisher
May 14, 2025

Bright Minds Biosciences (DRUG) to Release Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 13, 2025

TD Cowen Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy Recommendation - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Bright Minds stock rating initiated with Buy at TD Cowen - Investing.com Australia

May 13, 2025
pulisher
May 13, 2025

TD Cowen Initiates Coverage on Bright Minds Biosciences (DRUG) w - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Bright Minds stock rating initiated with Buy at TD Cowen By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Bright Minds (DRUG) Reports Promising Results in Epilepsy Research | DRUG Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Bright Minds reports BMB-101 eliminates drop attacks in mice By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101 - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Bright Minds (DRUG) Gains 'Buy' Rating from TD Cowen Analyst | D - GuruFocus

May 13, 2025
pulisher
May 10, 2025

Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Target Price at $83.25 - Defense World

May 10, 2025
pulisher
May 10, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Research Coverage Started at Chardan Capital - Defense World

May 10, 2025
pulisher
May 08, 2025

Chardan Capital Initiates a Buy Rating on Bright Minds Biosciences (DRUG) - The Globe and Mail

May 08, 2025
pulisher
May 07, 2025

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside - Benzinga

May 07, 2025
pulisher
May 07, 2025

(DRUG) On The My Stocks Page - news.stocktradersdaily.com

May 07, 2025
pulisher
May 07, 2025

Chardan Capital Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy Recommendation - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Chardan sets Bright Minds stock Buy rating, $80 target By Investing.com - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Chardan sets Bright Minds stock Buy rating, $80 target - Investing.com

May 07, 2025
pulisher
May 01, 2025

Piper Sandler Reaffirms Their Buy Rating on Bright Minds Biosciences (DRUG) - The Globe and Mail

May 01, 2025
pulisher
Apr 28, 2025

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study - The Manila Times

Apr 28, 2025
pulisher
Apr 28, 2025

Major Epilepsy Breakthrough? Phase 2 Trial Results for Revolutionary Seizure Drug Coming May 20 - Stock Titan

Apr 28, 2025
pulisher
Apr 27, 2025

Piper Sandler sets $93 target for Bright Minds Biosciences stock - MSN

Apr 27, 2025
pulisher
Apr 22, 2025

Uncover the Best-Performing Canadian Biotech Stocks of 2025 - Investing News Network

Apr 22, 2025
pulisher
Apr 22, 2025

When (DRUG) Moves Investors should Listen - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 16, 2025

Bright Minds Biosciences: A Buy With A Major Catalyst In Q2 2025 (NASDAQ:DRUG) - Seeking Alpha

Apr 16, 2025
pulisher
Apr 03, 2025

Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network

Apr 01, 2025
pulisher
Mar 26, 2025

(DRUG) Trading Advice - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 21, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Decrease in Short Interest - Defense World

Mar 21, 2025
pulisher
Mar 18, 2025

DRUG FY2025 EPS Estimate Decreased by Cantor Fitzgerald - The AM Reporter

Mar 18, 2025
pulisher
Mar 18, 2025

Cantor Fitzgerald Has Weak Forecast for DRUG FY2025 Earnings - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Trading Down 0.8% – Here’s Why - Defense World

Mar 15, 2025
pulisher
Mar 09, 2025

Bright Minds Biosciences Independent Director Nils Bottler Sells 100% Of Holding - simplywall.st

Mar 09, 2025
pulisher
Mar 04, 2025

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Bright Minds Biosciences Strengthens Epilepsy Focus with New Advisory Board Members - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Can These 5 Epilepsy Experts Accelerate Bright Minds' Breakthrough Drug Development? - StockTitan

Mar 04, 2025
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Capitalizzazione:     |  Volume (24 ore):